![Bernhard R. M. Ehmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bernhard R. M. Ehmer
Presidente presso
BIOTEST GMBH & CO. KGAA
Profilo
Bernhard R.
M.
Ehmer is currently Chairman-Supervisory Board at Biotest GmbH & Co. KGaA since 2022, Chairman at Swarm Oncology Ltd., Independent Non-Executive Director at Achilles Therapeutics Plc since 2022, Independent Member-Supervisory Board at Affimed NV since 2016, and Member-Supervisory Board at Affimed GmbH since 2016.
Former roles include Chief Executive Officer & Managing Director at Biopheresis GmbH and BioPheresis Technologies, Inc. from 2006 to 2007, President & Chief Executive Officer at Neovii Biotech GmbH from 2007 to 2008, Chairman-Management Board at Biotest GmbH & Co. KGaA. from 2014 to 2019, Chairman at Servier Symphogen.
A from 2018 to 2020, Director at ADMA Biologics, Inc. from 2017 to 2018, Director at Aton SA, Managing Director & Senior Vice President at ImClone Systems International GmbH from 2008 to 2012, VP, Head-Strategic Planning & Alliance Management at Merck KGaA from 1988 to 2006, Head-Therapeutics & Medical Operations at Boehringer Mannheim GmbH from 1986 to 1998, and President at ImClone Systems Corp.
from 2009 to 2014.
Education includes undergraduate degrees from Ruprecht-Karls-Universität Heidelberg and Ludwig-Maximilians-Universität München, both conferred in 1982.
Posizioni attive di Bernhard R. M. Ehmer
| Società | Posizione | Inizio |
|---|---|---|
| AFFIMED N.V. | Direttore/Membro del Consiglio | 21/01/2016 |
| ACHILLES THERAPEUTICS PLC | Direttore/Membro del Consiglio | 04/05/2022 |
| BIOTEST GMBH & CO. KGAA | Presidente | 05/05/2022 |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Direttore/Membro del Consiglio | 01/01/2016 |
Precedenti posizioni note di Bernhard R. M. Ehmer
| Società | Posizione | Fine |
|---|---|---|
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Presidente | 01/06/2020 |
| BIOTEST GMBH & CO. KGAA | Amministratore Delegato | 01/04/2019 |
| ADMA BIOLOGICS, INC. | Direttore/Membro del Consiglio | 15/02/2018 |
ImClone Systems Corp.
 ImClone Systems Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Presidente | 01/10/2014 |
ImClone Systems International GmbH
 ImClone Systems International GmbH BiotechnologyHealth Technology Develops novel therapeutic products | Corporate Officer/Principal | 01/01/2012 |
Formazione di Bernhard R. M. Ehmer
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
76
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Biotest AG
 Biotest AG Pharmaceuticals: OtherHealth Technology Develops, manufactures and distributes therapy medicinal products | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Biopheresis GmbH
 Biopheresis GmbH Miscellaneous Commercial ServicesCommercial Services Provides cancer treatments | Commercial Services |
BioPheresis Technologies, Inc.
 BioPheresis Technologies, Inc. Medical SpecialtiesHealth Technology Develops technology and medical devices for the treatment of cancer | Health Technology |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Develops and markets biopharmaceutical products | Health Technology |
Boehringer Mannheim GmbH | |
ImClone Systems International GmbH
ImClone Systems International GmbH BiotechnologyHealth Technology Develops novel therapeutic products | Health Technology |
ImClone Systems Corp.
ImClone Systems Corp. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Affimed GmbH
Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Provides business and private economic services | Commercial Services |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
